TVARDI THERAPEUTICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum
TVARDI THERAPEUTICS, INC. (TVRD) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum of 67.60% for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum · last filed 2026-08-14
- TVARDI THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, minimum for the quarter ending 2026-06-30 was 67.60%, a 0.40% decline year-over-year.
- TVARDI THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, minimum for the quarter ending 2025-06-30 was 67.87%.
- TVARDI THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, minimum for the quarter ending 2023-06-30 was 80.30%, a 3.21% increase year-over-year.
- TVARDI THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, minimum for the quarter ending 2023-03-31 was 76.30%, a 6.27% decline year-over-year.
- TVARDI THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, minimum for fiscal 2025 was 67.72%, a 24.42% decline from fiscal 2024.
- TVARDI THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, minimum for fiscal 2024 was 89.60%, a 17.43% increase from fiscal 2023.
- TVARDI THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, minimum for fiscal 2023 was 76.30%, a 1.80% decline from fiscal 2022.
- TVARDI THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, minimum for fiscal 2022 was 77.70%, a 8.52% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum 3 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum 6 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | 67.60% 10-Q · filed 2026-08-14 | 67.60% 10-Q · filed 2026-08-14 | ||||
| 2025-12-31 | 67.72% 10-K · filed 2026-03-31 | |||||
| 2025-09-30 | 67.72% 10-Q · filed 2025-11-13 | |||||
| 2025-06-30 | 67.87% 10-Q · filed 2026-08-14 | 67.87% 10-Q · filed 2026-08-14 | ||||
| 2024-12-31 | 89.60% 10-K · filed 2025-03-11 | |||||
| 2024-09-30 | 89.60% 10-Q · filed 2024-11-14 | |||||
| 2024-06-30 | 89.60% 10-Q · filed 2024-08-14 | |||||
| 2023-12-31 | 76.30% 10-K · filed 2025-03-11 | |||||
| 2023-09-30 | 76.30% 10-Q · filed 2024-11-14 | |||||
| 2023-06-30 | 80.30% 10-Q · filed 2024-08-14 | 76.30% 10-Q · filed 2024-08-14 | ||||
| 2023-03-31 | 76.30% 10-Q · filed 2024-05-13 | |||||
| 2022-12-31 | 77.70% 10-K · filed 2025-03-11 | |||||
| 2022-09-30 | 77.70% 10-Q · filed 2023-11-13 | 77.70% 10-Q · filed 2023-11-13 | ||||
| 2022-06-30 | 77.80% 10-Q · filed 2023-08-07 | 77.77% 10-Q · filed 2022-08-08 | 77.80% 10-Q · filed 2023-08-07 | 77.77% 10-Q · filed 2022-08-08 | ||
| 2022-03-31 | 81.40% 10-Q · filed 2023-05-15 | |||||
| 2021-12-31 | 71.60% 10-K · filed 2024-03-06 | |||||
| 2021-09-30 | 83.00% 10-Q · filed 2022-11-07 | 71.60% 10-Q · filed 2022-11-07 | ||||
| 2021-06-30 | 71.78% 10-Q · filed 2022-08-08 | 71.62% 10-Q · filed 2022-08-08 | ||||
| 2021-03-31 | 71.60% 10-Q · filed 2022-05-09 | 71.62% 10-Q · filed 2021-05-10 | ||||
| 2020-12-31 | 71.80% 10-K · filed 2023-03-06 | |||||
| 2020-09-30 | 72.60% 10-Q · filed 2021-11-08 | 72.60% 10-Q · filed 2021-11-08 | ||||
| 2020-06-30 | 73.73% 10-Q · filed 2021-08-09 | 73.72% 10-Q · filed 2021-08-09 | ||||
| 2020-03-31 | 73.72% 10-Q · filed 2021-05-10 | |||||
| 2019-12-31 | 71.10% 10-K · filed 2022-03-01 | |||||
| 2019-09-30 | 71.80% 10-Q · filed 2019-11-05 | 71.80% 10-Q · filed 2020-11-09 | ||||
| 2019-06-30 | 73.06% 10-Q · filed 2020-08-10 | 73.06% 10-Q · filed 2020-08-10 | ||||
| 2019-03-31 | 74.29% 10-Q · filed 2020-05-11 | |||||
| 2018-12-31 | 82.60% 10-K · filed 2021-02-25 | |||||
| 2018-09-30 | 82.60% 10-Q · filed 2019-11-05 | 82.60% 10-Q · filed 2019-11-05 | ||||
| 2018-06-30 | 85.70% 10-Q · filed 2019-08-07 | 85.70% 10-Q · filed 2019-08-07 | ||||
| 2017-12-31 | 75.30% 10-K · filed 2020-02-27 | |||||
| 2017-09-30 | 81.40% 10-Q · filed 2018-11-06 | 75.30% 10-Q · filed 2018-11-06 | ||||
| 2017-06-30 | 75.30% 10-Q · filed 2018-08-07 | |||||
| 2017-03-31 | 75.30% 10-Q · filed 2018-05-09 | |||||
| 2016-12-31 | 67.80% 10-K · filed 2019-03-12 | |||||
| 2016-09-30 | 67.80% 10-Q · filed 2017-11-02 | |||||
| 2016-06-30 | 69.30% 10-Q · filed 2017-08-03 | 67.80% 10-Q · filed 2017-08-03 | ||||
| 2016-03-31 | 67.80% 10-Q · filed 2017-05-04 | |||||
| 2015-12-31 | 64.00% 10-K · filed 2018-03-15 | |||||
| 2015-09-30 | 64.00% 10-Q · filed 2016-11-04 | |||||
| 2015-06-30 | 64.00% 10-Q · filed 2016-08-04 | |||||
| 2015-03-31 | 65.00% 10-Q · filed 2016-05-05 | |||||
| 2014-12-31 | 64.90% 10-K · filed 2017-03-10 | |||||
| 2014-09-30 | 65.00% 10-Q · filed 2015-11-09 | |||||
| 2014-06-30 | 65.00% 10-Q · filed 2015-08-10 | |||||
| 2014-03-31 | 67.00% 10-Q · filed 2015-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |